Lipopolysaccharide-mediated mast cell activation induces IFN-γ secretion by NK cells

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 119-125

  Vosskuhl, Katja ^a   Greten, Tim F ^a   Manns, Michael P ^a   Korangy, Firouzeh ^a   Wedemeyer, Jochen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; LIPOPOLYSACCHARIDE; OX40 LIGAND; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TLR3 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; MAST CELL; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL COMMUNICATION; CELL CULTURE; COCULTURE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION;

ANIMALS; BONE MARROW CELLS; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956214725     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902406     Document Type: Article

References (55)

1. Metz, M., and M. Maurer. 2007. Mast cells - key effector cells in immune responses. Trends Immunol. 28: 234-241.
2. Wedemeyer, J., M. Tsai, and S. J. Galli. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12: 624-631.
3. Männel, D. N., L. Hültner, and B. Echtenacher. 1996. Critical protective role of mast cell-derived tumour necrosis factor in bacterial infection. Res. Immunol. 147: 491-493.
4. Echtenacher, B., D. N. Männel, and L. Hültner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77.
5. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381: 77-80.
6. Malaviya, R., and S. N. Abraham. 2001. Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179: 16-24.
7. Maurer, M., B. Echtenacher, L. Hültner, G. Kollias, D. N. Männel, K. E. Langley, and S. J. Galli. 1998. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188: 2343-2348.
8. Prodeus, A. P., X. Zhou, M. Maurer, S. J. Galli, and M. C. Carroll. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390: 172-175.
9. Maurer, M., J. Wedemeyer, M. Metz, A. M. Piliponsky, K. Weller, D. Chatterjea, D. E. Clouthier, M. M. Yanagisawa, M. Tsai, and S. J. Galli. 2004. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432: 512-516.
10. McCurdy, J. D., T. J. Olynych, L. H. Maher, and J. S. Marshall. 2003. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170: 1625-1629.
11. McCurdy, J. D., T. J. Lin, and J. S. Marshall. 2001. Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol. 70: 977-984.
12. Supajatura, V., H. Ushio, A. Nakao, S. Akira, K. Okumura, C. Ra, and H. Ogawa. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109: 1351-1359.
13. Supajatura, V., H. Ushio, A. Nakao, K. Okumura, C. Ra, and H. Ogawa. 2001. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167: 2250-2256. (Pubitemid 32747537)
14. Varadaradjalou, S., F. Féger, N. Thieblemont, N. B. Hamouda, J. M. Pleau, M. Dy, and M. Arock. 2003. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33: 899-906.
15. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
16. Nakae, S., H. Suto, G. J. Berry, and S. J. Galli. 2007. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 109: 3640-3648.
17. Nakae, S., H. Suto, M. Iikura, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. 2006. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176: 2238-2248.
18. Nakae, S., H. Suto, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. 2005. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 102: 6467-6472.
19. Suto, H., S. Nakae, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. 2006. Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 176: 4102-4112.
20. Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002.
21. Mekori, Y. A., and D. D. Metcalfe. 1999. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104: 517-523.
22. Henz, B. M., M. Maurer, U. Lippert, M. Worm, and M. Babina. 2001. Mast cells as initiators of immunity and host defense. Exp. Dermatol. 10: 1-10.
23. Cumberbatch, M., R. J. Dearman, C. E. Griffiths, and I. Kimber. 2000. Langerhans cell migration. Clin. Exp. Dermatol. 25: 413-418.
24. Burke, S. M., T. B. Issekutz, K. Mohan, P. W. Lee, M. Shmulevitz, and J. S. Marshall. 2008. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 111: 5467-5476.
25. Dokun, A. O., D. T. Chu, L. Yang, A. S. Bendelac, and W. M. Yokoyama. 2001. Analysis of in situ NK cell responses during viral infection. J. Immunol. 167: 5286-5293.
26. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106: 2252-2258.
27. Derby, E. G., V. Reddy, E. L. Nelson, W. C. Kopp, M. W. Baseler, J. R. Dawson, and A. M. Malyguine. 2001. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production. Cytokine 13: 85-90.
28. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
29. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
30. Morris, S. C., T. Orekhova, M. J. Meadows, S. M. Heidorn, J. Yang, and F. D. Finkelman. 2006. IL-4 induces in vivo production of IFN-gamma by NK and NKT cells. J. Immunol. 176: 5299-5305.
31. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156: 4746-4756.
32. Xu, J., A. K. Chakrabarti, J. L. Tan, L. Ge, A. Gambotto, and N. L. Vujanovic. 2007. Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk. Blood 109: 3333-3341.
33. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
34. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331-367.
35. Hernandez-Hansen, V., J. D. Bard, C. A. Tarleton, J. A. Wilder, C. A. Lowell, B. S. Wilson, and J. M. Oliver. 2005. Increased expression of genes linked to FcepsilonRI Signaling and to cytokine and chemokine production in Lyndeficient mast cells. J. Immunol. 175: 7880-7888.
36. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786.
37. Galli, S. J. 2000. Mast cells and basophils. Curr. Opin. Hematol. 7: 32-39.
38. Ando, A., T. R. Martin, and S. J. Galli. 1993. Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses. J. Clin. Invest. 92: 1639-1649.
39. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328: 257-265.
40. Metcalfe, D. D., D. Baram, and Y. A. Mekori. 1997. Mast cells. Physiol. Rev. 77: 1033-1079.
41. Galli, S. J., M. Tsai, and A. M. Piliponsky. 2008. The development of allergic inflammation. Nature 454: 445-454.
42. Cooper, M. A., T. A. Fehniger, S. C. Turner, K. S. Chen, B. A. Ghaheri, T. Ghayur, W. E. Carson, and M. A. Caligiuri. 2001. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97: 3146-3151.
43. Wendt, K., E. Wilk, S. Buyny, J. Buer, R. E. Schmidt, and R. Jacobs. 2006. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J. Leukoc. Biol. 80: 1529-1541.
44. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176: 1517-1524.
45. Vahlne, G., S. Becker, P. Brodin, and M. H. Johansson. 2008. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand. J. Immunol. 67: 1-11.
46. Etogo, A. O., J. Nunez, C. Y. Lin, T. E. Toliver-Kinsky, and E. R. Sherwood. 2008. NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis. J. Immunol. 180: 6334-6345.
47. Kim, S., K. Iizuka, H. L. Aguila, I. L. Weissman, and W. M. Yokoyama. 2000. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 97: 2731-2736.
48. Emoto, M., M. Miyamoto, I. Yoshizawa, Y. Emoto, U. E. Schaible, E. Kita, and S. H. Kaufmann. 2002. Critical role of NK cells rather than V alpha 14(+) NKT cells in lipopolysaccharide-induced lethal shock in mice. J. Immunol. 169: 1426-1432.
49. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J. Immunol. 149: 1666-1670.
50. Heinzel, F. P. 1990. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 145: 2920-2924.
51. Schroder, K., M. J. Sweet, and D. A. Hume. 2006. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211: 511-524.
52. Nautiyal, K. M., H. McKellar, A. J. Silverman, and R. Silver. 2009. Mast cells are necessary for the hypothermic response to LPS-induced sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R595-R602.
53. Liu, C. W., Y. Y. Lou, G. Lizée, H. Qin, S. J. Liu, B. Rabinovich, G. J. Kim, Y. H. Wang, Y. Ye, A. G. Sikora, et al. 2008. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J. Clin. Invest. 118: 1165-1175.
54. Gri, G., S. Piconese, B. Frossi, V. Manfroi, S. Merluzzi, C. Tripodo, A. Viola, S. Odom, J. Rivera, M. P. Colombo, and C. E. Pucillo. 2008. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29: 771-781.
55. Kashiwakura, J., H. Yokoi, H. Saito, and Y. Okayama. 2004. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173: 5247-5257.